03/20/2025
4:29 PM | Intra-Cellular Therapies (Filer)
| Form 10-K/A | |
03/18/2025
4:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:26 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:01 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
03/04/2025
5:01 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ITCI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intra-Cellular Therapies and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:00 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
4:21 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
02/21/2025
8:00 AM | Intra-Cellular Therapies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
7:21 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
9:23 AM | FMR LLC (Filed by)
Intra-Cellular Therapies (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
4:29 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:31 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:32 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:01 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
4:25 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
01/13/2025
4:27 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
01/13/2025
4:27 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
01/13/2025
6:47 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:48 AM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
01/10/2025
5:46 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:27 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
6:38 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:53 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Intra-Cellular Therapies (Subject)
| Form SC 13G/A | |
10/15/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
11:36 AM | Intra-Cellular Therapies (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
10/02/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Secret Weapon (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today |
09/06/2024
4:43 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:06 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:34 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:34 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:36 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:09 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
5:03 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:55 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:49 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
7:00 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:04 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:05 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:05 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:05 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:28 PM | Intra-Cellular Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/21/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:02 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
5:02 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:40 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:43 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:46 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
04/29/2024
3:48 PM | Intra-Cellular Therapies (Filer)
| Form ARS | |
04/24/2024
3:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024
4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ITCI Stock Free ITCI Stock Alerts